Literature DB >> 10600041

Drugs used in physician-assisted death.

D L Willems1, J H Groenewoud, G van der Wal.   

Abstract

Epidemiological studies, case reports, and recommendations concerning the drugs used in physician-assisted death are reviewed in this paper. Using a MEDLINE and Cancerlit search, we found a total of 20 relevant publications. Recent research, mainly from the Netherlands, has shown that high doses of barbiturates are usually effective for physician-assisted suicide, while a combination of a barbiturate and a derivative of curare are effective for euthanasia. Opioids are less reliable drugs for physician-assisted death because of the unpredictable duration of the dying process even after high doses. The same applies to benzodiazepines. The most frequent undesired effect is an unexpectedly long dying process due to impaired uptake of the drugs. Although the evidence base is incomplete, the Dutch recommendations issued in 1994 and renewed in 1998 do not seem inappropriate.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; Royal Dutch Pharmaceutical Association

Mesh:

Substances:

Year:  1999        PMID: 10600041     DOI: 10.2165/00002512-199915050-00001

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  30 in total

1.  Letter: Metabolism of barbiturate after overdosage.

Authors:  D J Sumner; J Kalk; B Whiting
Journal:  Br Med J       Date:  1975-02-08

2.  Death and dignity. A case of individualized decision making.

Authors:  T E Quill
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

3.  Terminal sedation in the care of dying patients.

Authors:  P Rousseau
Journal:  Arch Intern Med       Date:  1996-09-09

4.  Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in the Netherlands, 1990-1995.

Authors:  P J van der Maas; G van der Wal; I Haverkate; C L de Graaff; J G Kester; B D Onwuteaka-Philipsen; A van der Heide; J M Bosma; D L Willems
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

5.  Euthanatics: implementation of a protocol to standardise euthanatics among pharmacists and GPs.

Authors:  B D Onwuteaka-Philipsen; M T Muller; G van der Wal
Journal:  Patient Educ Couns       Date:  1997-06

6.  Influence of nutritional status on the pharmacokinetics and pharmacodynamics of pentobarbital.

Authors:  D Jung; P P Prasad
Journal:  Drug Metab Dispos       Date:  1989 Jul-Aug       Impact factor: 3.922

7.  Attempted suicide by insulin overdose in insulin-requiring diabetics.

Authors:  F I Martin; N Hansen; G L Warne
Journal:  Med J Aust       Date:  1977-01-15       Impact factor: 7.738

8.  Fatal hyperkalemia from accidental overdose of potassium chloride.

Authors:  C V Wetli; J H Davis
Journal:  JAMA       Date:  1978-09-22       Impact factor: 56.272

9.  Palliative options of last resort: a comparison of voluntarily stopping eating and drinking, terminal sedation, physician-assisted suicide, and voluntary active euthanasia.

Authors:  T E Quill; B Lo; D W Brock
Journal:  JAMA       Date:  1997-12-17       Impact factor: 56.272

Review 10.  Practical issues in physician-assisted suicide.

Authors:  M A Drickamer; M A Lee; L Ganzini
Journal:  Ann Intern Med       Date:  1997-01-15       Impact factor: 25.391

View more
  1 in total

1.  Health care professionals' comprehension of the legal status of end-of-life practices in Quebec: study of clinical scenarios.

Authors:  Isabelle Marcoux; Antoine Boivin; Claude Arsenault; Mélanie Toupin; Joseph Youssef
Journal:  Can Fam Physician       Date:  2015-04       Impact factor: 3.275

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.